Cargando…
A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality
Since December 2019, coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has changed our lives. Elderly and those with comorbidities represent the vast majority of patients hospitalized with severe COVID-19 symptoms, including a...
Autores principales: | Camelo, Serge, Latil, Mathilde, Agus, Sam, Dioh, Waly, Veillet, Stanislas, Lafont, René, Dilda, Pierre J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648031/ https://www.ncbi.nlm.nih.gov/pubmed/34783636 http://dx.doi.org/10.1080/22221751.2021.2006579 |
Ejemplares similares
-
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response
por: Mileto, D., et al.
Publicado: (2021) -
Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status
por: Boschi, Celine, et al.
Publicado: (2021) -
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021) -
Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination
por: Iketani, Sho, et al.
Publicado: (2021) -
Susceptibility of livestock to SARS-CoV-2 infection
por: Bosco-Lauth, Angela M., et al.
Publicado: (2021)